
Alimera Sciences ALIM
Quarterly report 2024-Q2
added 08-07-2024
Alimera Sciences P/S Ratio 2011-2025 | ALIM
Annual P/S Ratio Alimera Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.26 | 0.226 | 0.505 | 0.712 | 0.602 | 0.0845 | 0.147 | 0.12 | 0.305 | 1.74 | 7.33 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.33 | 0.0845 | 1.18 |
P/S Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
0.528 | $ 1.2 | 0.42 % | $ 129 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
77.6 | $ 2.65 | -0.36 % | $ 1.39 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | ||
|
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Aurora Cannabis
ACB
|
3.73 | $ 4.33 | -3.56 % | $ 86.3 M | ||
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Zomedica Corp.
ZOM
|
5.45 | - | -0.21 % | $ 98 M | ||
|
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M | ||
|
Emergent BioSolutions
EBS
|
0.132 | $ 12.14 | -2.29 % | $ 622 M | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | $ 21.52 | -0.32 % | $ 2.05 B | ||
|
Evolus
EOLS
|
3.33 | $ 6.65 | -3.62 % | $ 412 M | ||
|
Harrow Health
HROW
|
2.67 | $ 50.27 | 0.36 % | $ 1.64 B | ||
|
China Pharma Holdings
CPHI
|
1 | $ 1.27 | -1.17 % | $ 22.2 M | ||
|
OrganiGram Holdings
OGI
|
4.82 | $ 1.72 | -4.19 % | $ 402 M | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
Organogenesis Holdings
ORGO
|
0.86 | $ 5.15 | -2.37 % | $ 678 M | ||
|
Bausch Health Companies
BHC
|
0.386 | $ 7.12 | -1.11 % | $ 2.6 B | ||
|
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 3.64 | 0.41 % | $ 4.52 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 3.86 | -6.31 % | $ 54.3 M | ||
|
Rockwell Medical
RMTI
|
0.424 | $ 0.81 | -6.32 % | $ 18.9 M | ||
|
Pacira BioSciences
PCRX
|
5.13 | $ 26.28 | -0.87 % | $ 1.22 B | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.72 | -0.87 % | $ 3.37 M | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | ||
|
Veru
VERU
|
6.39 | $ 2.24 | -6.67 % | $ 302 M | ||
|
Perrigo Company plc
PRGO
|
0.905 | $ 13.78 | -0.29 % | $ 1.89 B | ||
|
ProPhase Labs
PRPH
|
1.06 | $ 0.44 | -15.33 % | $ 6.97 M | ||
|
cbdMD
YCBD
|
0.0863 | $ 1.5 | -12.06 % | $ 6.47 M | ||
|
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
0.434 | $ 9.61 | -3.37 % | $ 683 M | ||
|
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
0.502 | $ 0.63 | 6.88 % | $ 30.1 M | ||
|
Tilray
TLRY
|
1.9 | $ 9.26 | -3.5 % | $ 5.72 B | ||
|
TherapeuticsMD
TXMD
|
18.4 | $ 1.74 | - | $ 18.2 M |